Bruce Haffty, MD
Research & Publications
Biography
News
Coauthors
Selected Publications
- Abstract PO4-22-04: Evaluation of acute toxicity in breast cancer patients receiving concurrent capecitabine and radiationShalaby A, Sherwani Z, Hathout L, Jan I, Haffty B, George M, Kumar S, Omene C, Toppmeyer D, Ohri N. Abstract PO4-22-04: Evaluation of acute toxicity in breast cancer patients receiving concurrent capecitabine and radiation. Cancer Research 2024, 84: po4-22-04-po4-22-04. DOI: 10.1158/1538-7445.sabcs23-po4-22-04.
- Abstract PO5-22-02: Evaluation of a surface-guided and tattoo-less approach to setup for whole breast radiotherapyZhang X, Mamidanna S, Zhang Y, Wang X, Yue N, Kumar S, Potdevin L, Kowzun M, George M, Hathout L, Haffty B, Ohri N. Abstract PO5-22-02: Evaluation of a surface-guided and tattoo-less approach to setup for whole breast radiotherapy. Cancer Research 2024, 84: po5-22-02-po5-22-02. DOI: 10.1158/1538-7445.sabcs23-po5-22-02.
- Abstract GS02-08: Five-year outcomes of the IDEA trial of endocrine therapy without radiotherapy after breast-conserving surgery for postmenopausal patients age 50-69 with genomically-selected favorable Stage I breast cancerJagsi R, Griffith K, Harris E, Wright J, Recht A, Taghian A, Lee L, Moran M, Small W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell S, Sharp J, Sabel M, Schott A, El-Tamer M. Abstract GS02-08: Five-year outcomes of the IDEA trial of endocrine therapy without radiotherapy after breast-conserving surgery for postmenopausal patients age 50-69 with genomically-selected favorable Stage I breast cancer. Cancer Research 2024, 84: gs02-08-gs02-08. DOI: 10.1158/1538-7445.sabcs23-gs02-08.
- Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectivesKim J, Fahmy V, Haffty B. Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectives. Expert Review Of Anticancer Therapy 2024, 24: 211-217. PMID: 38502143, DOI: 10.1080/14737140.2024.2333320.
- Reply to G.B. Mann et al and S. SorscherJagsi R, Griffith K, Harris E, Wright J, Recht A, Taghian A, Lee L, Moran M, Small W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell S, Sharp J, Sabel M, Schott A, El-Tamer M. Reply to G.B. Mann et al and S. Sorscher. Journal Of Clinical Oncology 2024, 42: 1998-2000. PMID: 38489573, DOI: 10.1200/jco.24.00224.
- The Present and Future of Postmastectomy RadiationOhri N, George M, Omene C, Haffty B. The Present and Future of Postmastectomy Radiation. International Journal Of Radiation Oncology • Biology • Physics 2024, 118: 466-467. PMID: 38220259, DOI: 10.1016/j.ijrobp.2023.10.002.
- Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEAJagsi R, Griffith K, Harris E, Wright J, Recht A, Taghian A, Lee L, Moran M, Small W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell S, Sharp J, Sabel M, Schott A, El-Tamer M. Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA. Journal Of Clinical Oncology 2023, 42: 390-398. PMID: 38060195, DOI: 10.1200/jco.23.02270.
- Poly(ADP-ribose) polymerase-1 (PARP-1) expression in patients treated with breast-conserving surgery and radiation therapy (BCS+RT).Goswami J, Goyal S, Wu H, Moran M, Haffty B. Poly(ADP-ribose) polymerase-1 (PARP-1) expression in patients treated with breast-conserving surgery and radiation therapy (BCS+RT). Journal Of Clinical Oncology 2010, 28: 582-582. DOI: 10.1200/jco.2010.28.15_suppl.582.